Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    26.00 (2.47%)
Bid:
1,071.00
Ask:
1,072.00
Spread: 1.00 (0.093%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Director/PDMR Shareholding

27 Mar 2023 15:44

RNS Number : 3560U
Persimmon PLC
27 March 2023
Β 

Β 

27 March 2023

Persimmon Plc (the "Company")

Β 

Director/PDMR Shareholding

Β 

Persimmon Plc announces that on 23 March 2023 and 27 March 2023 Jason Windsor, Chief Financial Officer, acquired 9,284 and 7,943 shares in the Company, respectively, in respect of the vesting of awards granted in July 2022 as compensation for share awards forfeited on leaving his previous employer. Also, on 23 March 2023 and 27 March 2023, Jason Windsor sold 4,371 and 3,740 shares in the Company, respectively, to settle the tax liability arising on the vesting of the awards and has retained the balance of the shares.Β 

Β 

The below notification, made in accordance with the requirements of article 19.3 of the UK Market Abuse Regulation, gives further details:

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Jason Windsor

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Financial Officer

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Persimmon Plc

b)

Β 

LEI

Β 

213800XI72Y57UWN6F31

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Transaction 1

a)

Β 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

Identification code

GB0006825383

b)

Β 

Nature of the transaction

Β 

Β 

Acquisition of shares following the vesting of an award granted in July 2022, as compensation for a 2020 deferred bonus share award forfeited by Jason Windsor on leaving his previous employer.

c)

Β 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

9,284

Β 

Β 

d)

Β 

Aggregated information

- Aggregated volume

N/A Single transaction

- Price

N/A Single transaction

e)

Β 

Date of the transaction

Β 

23 March 2023

f)

Place of the transaction

Β 

Outside a trading venue

Transaction 2

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Ordinary shares of 10p each

Β 

Β 

Β 

GB0006825383

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Sale of shares to settle tax liability on vesting of award in respect of the forfeited 2020 deferred bonus share award.

c)

Β 

Price(s) and volume(s)

Price(s)

Volume(s)

Β£12.26

4,371

Β 

Β 

d)

Β 

Aggregated information

- Aggregated volume

N/A Single transaction

- Price

N/A Single transaction

e)

Β 

Date of the transaction

Β 

23 March 2023

f)

Place of the transaction

Β 

London Stock Exchange (XLON); Main Market

Transaction 3

a)

Β 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

Identification code

GB0006825383

b)

Β 

Nature of the transaction

Β 

Β 

Acquisition of shares following the vesting of an award granted in July 2022, as compensation for a 2021 deferred bonus share award forfeited by Jason Windsor on leaving his previous employer.

c)

Β 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

7,943

Β 

Β 

d)

Β 

Aggregated information

- Aggregated volume

N/A Single transaction

- Price

N/A Single transaction

e)

Β 

Date of the transaction

Β 

27 March 2023

f)

Place of the transaction

Β 

Outside a trading venue

Transaction 4

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Ordinary shares of 10p each

Β 

Β 

Β 

GB0006825383

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Sale of shares to settle tax liability on vesting of award in respect of the forfeited 2021 deferred bonus share award.

c)

Β 

Price(s) and volume(s)

Price(s)

Volume(s)

Β£12.13

3,740

Β 

Β 

d)

Β 

Aggregated information

- Aggregated volume

N/A Single transaction

- Price

N/A Single transaction

e)

Β 

Date of the transaction

Β 

27 March 2023

f)

Place of the transaction

Β 

London Stock Exchange (XLON); Main Market

Β 

Β 

Tracy Davison

Company Secretary

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHEALDXADNDEFA
Date   Source Headline
1st Jun 202610:06 amRNSAdmission to Trading
1st Jun 202610:03 amRNSTotal Voting Rights
29th May 202611:57 amRNSDirector/PDMR Shareholding
11th May 20264:56 pmRNSHolding(s) in Company
1st May 202612:12 pmRNSAdmission to Trading
1st May 202612:06 pmRNSTotal Voting Rights
30th Apr 20262:19 pmRNSResult of AGM
30th Apr 20262:18 pmRNSHolding(s) in Company
30th Apr 20267:00 amRNSAGM Trading Statement
23rd Apr 20269:21 amRNSHolding(s) in Company
1st Apr 20261:45 pmRNSAdmission to Trading
1st Apr 20261:43 pmRNSTotal Voting Rights
30th Mar 20263:06 pmRNSDirector/PDMR Shareholding
24th Mar 20263:20 pmRNSDirector/PDMR Shareholding
23rd Mar 20262:12 pmRNSAnnual Report 2025 and Notice of AGM 2026
10th Mar 20267:00 amRNSFull Year Results
2nd Mar 202611:26 amRNSTotal Voting Rights
18th Feb 20261:33 pmRNSNew Issue of Equity Securities
2nd Feb 202610:00 amRNSTotal Voting Rights
13th Jan 20267:00 amRNS2025 Trading Statement
2nd Jan 202612:52 pmRNSTotal Voting Rights
2nd Jan 202611:09 amRNSHolding(s) in Company
30th Dec 20254:44 pmRNSHolding(s) in Company
30th Dec 20254:44 pmRNSHolding(s) in Company
24th Dec 202512:29 pmRNSHolding(s) in Company
24th Dec 202512:29 pmRNSHolding(s) in Company
22nd Dec 20252:22 pmRNSHolding(s) in Company
22nd Dec 20252:22 pmRNSHolding(s) in Company
1st Dec 20252:58 pmRNSBlock listing Interim Review
1st Dec 202512:39 pmRNSTotal Voting Rights
27th Nov 202511:47 amRNSHolding(s) in Company
13th Nov 20257:00 amRNSQ3 Trading Statement
3rd Nov 202511:43 amRNSTotal Voting Rights
1st Oct 202511:45 amRNSTotal Voting Rights
30th Sep 202512:58 pmRNSDirector/PDMR Shareholding
26th Sep 20255:33 pmRNSHolding(s) in Company
17th Sep 20254:44 pmRNSHolding(s) in Company
9th Sep 202510:14 amRNSDirector/PDMR Shareholding
1st Sep 20252:31 pmRNSTotal Voting Rights
13th Aug 20257:00 amRNSHalf Year Results
1st Aug 202511:36 amRNSTotal Voting Rights
9th Jul 20257:23 amRNSUK CMA proposes closure of its investigation
4th Jul 20251:44 pmRNSHolding(s) in Company
1st Jul 202511:38 amRNSTotal Voting Rights
17th Jun 20253:47 pmRNSHolding(s) in Company
2nd Jun 20253:07 pmRNSBlock listing Interim Review
2nd Jun 202511:39 amRNSTotal Voting Rights
14th May 20257:00 amRNSSale of FibreNest
1st May 20252:20 pmRNSResult of AGM
1st May 20252:02 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.